Search results for "Hep"

showing 10 items of 12243 documents

Activités cytotoxiques et pro-oxydantes d'acides gras à très longue chaîne sur des oligodendrocytes murins sauvages et déficients en Abcd1 et Acox1 :…

2010

X-ALD and P-NALD are two rare, peroxisomal metabolic and neurodegenerative diseases. ABCD1 and ACOX1 are known to be responsible for X-ALD and P-NALD, respectively. The actively demyelinating lesions in CNS, exhibited signs of oxidative stress and cell death. The accumulation of VLCFA in plasma and tissue is the biochemical common hallmark to both diseases. First, we characterized a murine oligodendrocytes cell line 158N to use it as a model. This 158N cell line which has characteristics of mature oligodendrocytes (expression of myelin proteins MOG, MBP, PLP), has also functional peroxisomes with Abcd1 and Acox1 proteins. Then, we studied the cytotoxic and pro-oxidative effects of VLCFA (C2…

X-ALD[SDV.SA]Life Sciences [q-bio]/Agricultural sciences[SDV.SA] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyOligodendrocytesP-NALDLysosomeProtéines de myélineStress oxydantMort cellulaire[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyNo english keywordsPeroxysome[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S01688278173…

2018

It has come to our attention that the PITER framework investigator, Alessandro Federico, was incorrectly listed as F. Alessandro in the original manuscript. Please note that the correct name of this author is Alessandro Federico (2nd University of Naples). The correct list of PITER investigators is in the footnote below.

HepatologyHepatitis B; EASL guidelines; Treatment; Interferon; Entecavir; Tenofovir; TAF; HBsAg; Hepatocellular carcinoma; HBV DNA; HBV reactivation; Mother to child transmissionHepatocellular carcinomaHBV reactivationEASL guidelinesHepatitis BEntecavirTreatmentHBsAgTAFHBV DNAMother to child transmissionInterferonTenofovirEASL guideline
researchProduct

Kathepsinaktivit�t in Placenten verschiedener Altersstufen

1954

In Placenten verschiedener Altersstufen wurde nach der Methode vonAnson die Kathepsinaktivitat bestimmt. Dabei zeigte sich, das gegenuber der Fruhgraviditat die Aktivitat am Ende der Schwangerschaft deutlich erniedrigt ist. Bemerkenswert ist die Gruppe der echten Schwangerschaftsubertragungen, die die niedrigsten Werte aufwiesen. Die Differenzen zwischen den einzelnen Gruppen sind statistisch signifikant. Die Bedeutung der Fermentaktivitat fur das Wachstum wird diskutiert.

Cathepsinmedicine.anatomical_structurebusiness.industryPlacentaObstetrics and GynecologyMedicineGeneral MedicinebusinessMolecular biologyArchiv f�r Gyn�kologie
researchProduct

The rational use of albumin in patients with cirrhosis and ascites

2004

Abstract Background. Ascites is one of the most frequent severe complications in patients with liver cirrhosis. The treatment of this chronic disease usually requires the prolonged use of albumin, frequently continued even after patients’ discharge from the hospital. Aims. Aim of the study was to define a consensus among Italian physicians with regard to the use of albumin in patients with decompensated cirrhosis and ascites. Methods. The study adopted the Delphi technique to conduct the consensus activities. All controversial issues related to the use of albumin were identified by the experts’ board and proposed to the 68 participating hepatology centres through two subsequent questionnair…

medicine.medical_specialtyCirrhosisHepatologybusiness.industryGastroenterologyDelphi methodAlbuminHepatologymedicine.diseaseInternal medicineAscitesmedicineHypoalbuminemiamedicine.symptomMedical prescriptionIntensive care medicinebusinessSocioeconomic statusDigestive and Liver Disease
researchProduct

Lebermetastasen kolorektaler Karzinome - wie oft kann man operieren?

2007

Recurrent liver metastases of colorectal carcinoma are frequent. The repeat hepatectomy is superior to other therapeutic options. In about 20 % of patients with recurrent liver metastases a complete resection (R 0) is possible. The morbidity of repeat hepatectomy is similar to that of first hepatectomy. The 5-year survival rate after repeat hepatectomy ranges between 30 and 40 %. Often in the follow-up additional operations become necessary for extrahepatic recurrencies. For determination of the optimal therapy an interdisciplinary approach must be chosen.

medicine.medical_specialtybusiness.industryColorectal cancermedicine.medical_treatmentRepeat hepatectomymedicine.diseaseComplete resectionSurgeryText miningmedicineSurgeryOperative therapyHepatectomybusinessSurvival rateZentralblatt für Chirurgie
researchProduct

Consumo de hierbas medicinales en los pacientes de consultas externas de digestivo

2004

Resumen El consumo de hierbas medicinales constituye uno de los capitulos mas importantes de la medicina alternativa y complementaria (MAC). Su uso frecuente en la poblacion general determina la posibilidad de efectos terapeuticos o toxicos que pueden incidir en los pacientes que acuden a la medicina oficial. Para conocer la frecuencia de uso, las especies consumidas y el perfil del consumidor de hierbas medicinales entre los pacientes de patologia digestiva, se entrevisto a los enfermos que acudian a consultas externas de la especialidad, en el hospital comarcal Francesc de Borja (Gandia), durante 5 meses, y se recogieron 539 encuestas validas. El 34,7% de las personas encuestadas habia co…

Hepatologybusiness.industryGastroenterologyMedicinebusinessHumanitiesGastroenterología y Hepatología
researchProduct

Meson and glueball spectroscopy within the graviton soft wall model

2021

The graviton soft wall model (GSW) provides a unified description of the scalar glueball and meson spectra with a unique energy scale. This success has led us to extend the analysis to the description of the spectra of other hadrons. We use this model to calculate masses of the odd and even ground states of glueballs for various spins, and show that the GSW model is able to reproduce the Regge trajectory of these systems. In addition, the spectra of the $\rho$, $a_1$ and the $\eta$ mesons will be addressed. Results are in excellent agreement with current experimental data.Furthermore such an achievement is obtained without any additional parameters. Indeed, the only two parameters appearing…

PhysicsParticle physicsMeson010308 nuclear & particles physicsGlueballHigh Energy Physics::LatticeHadronScalar (mathematics)High Energy Physics::PhenomenologyGravitonOrder (ring theory)FOS: Physical sciences01 natural sciencesHigh Energy Physics - PhenomenologyHigh Energy Physics - Phenomenology (hep-ph)0103 physical sciencesDilatonHigh Energy Physics::Experiment010306 general physicsScalar meson
researchProduct

MBOAT7 locus rs641738 variant predisposes to hepatocellular carcinoma in nonalcoholic fatty liver

2016

nonalcoholic fatty liver diseaseHepatologyHepatocellular carcinomabusiness.industrySettore MED/12 - GASTROENTEROLOGIAFatty liverGastroenterologyLocus (genetics)medicine.diseaseHepatocellular carcinoma; nonalcoholic fatty liver disease03 medical and health sciences0302 clinical medicineN/A030220 oncology & carcinogenesisHepatocellular carcinomaNonalcoholic fatty liver diseasemedicineCancer research030211 gastroenterology & hepatologybusinessDigestive and Liver Disease
researchProduct

Determination of the LEP centre-of-mass energy from Zγ events

1999

Radiative returns to the Z resonance (Zgamma events) are used to determine the LEP2 centre-of-mass energy from the data collected with the ALEPH detector in 1997. The average centre-of-mass energy is measured to be: E_CM = 182.50 +- 0.19(stat) +- 0.08(syst) GeV in good agreement with the precise determination by the LEP energy working group of 182.652 +- 0.050 GeV. If applied to the measurement of the W mass, its precision translates into a systematic error on M_W which is smaller than the statistical error achieved from the corresponding dataset.

Systematic errorPhysicsNuclear and High Energy PhysicsParticle physicsAleph[PHYS.HEXP] Physics [physics]/High Energy Physics - Experiment [hep-ex]010308 nuclear & particles physicsElectron–positron annihilationDetectorFOS: Physical sciences01 natural sciencesResonance (particle physics)High Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Radiative transferStatistical errorHigh Energy Physics::Experiment010306 general physicsParticle Physics - ExperimentEnergy (signal processing)
researchProduct

Molecular surveillance of norovirus, 2005–16 : an epidemiological analysis of data collected from the NoroNet network

2018

BACKGROUND: The development of a vaccine for norovirus requires a detailed understanding of global genetic diversity of noroviruses. We analysed their epidemiology and diversity using surveillance data from the NoroNet network.METHODS: We included genetic sequences of norovirus specimens obtained from outbreak investigations and sporadic gastroenteritis cases between 2005 and 2016 in Europe, Asia, Oceania, and Africa. We genotyped norovirus sequences and analysed sequences that overlapped at open reading frame (ORF) 1 and ORF2. Additionally, we assessed the sampling date and country of origin of the first reported sequence to assess when and where novel drift variants originated.FINDINGS: W…

0301 basic medicineDatabases FactualvirusesVARIANTSmedicine.disease_causeDisease OutbreaksEMERGENCEfluids and secretions[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesEpidemiologyGenotypeTOOLmedia_commonCaliciviridae InfectionsMolecular Epidemiologyvirus diseasesrespiratory system3. Good healthGastroenteritis[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesInfectious DiseasesGeography[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyRNA Viral[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyOUTBREAKSmedicine.medical_specialtyEUROPEGenotypeTRANSMISSIONVIRUSES[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/Virology03 medical and health sciencesSDG 3 - Good Health and Well-beingGenetic driftEnvironmental healthmedicinemedia_common.cataloged_instanceHumansEuropean unionRetrospective StudiesGenetic diversityMolecular epidemiologyNorovirusOutbreakGenetic Variation[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyADULTSdigestive system diseasesEVOLUTION030104 developmental biology3121 General medicine internal medicine and other clinical medicineNorovirushuman activities
researchProduct